vimarsana.com
Home
Live Updates
Viatris inks $264M deal to resolve long-running EpiPen pay-f
Viatris inks $264M deal to resolve long-running EpiPen pay-f
Viatris inks $264M deal to resolve long-running EpiPen pay-for-delay case
Viatris got a big win in June of last year when a Kansas City judge ruled the co
Related Keywords
,
Mylan ,
Viatris ,
Pfizer ,
Teva Pharmaceuticals ,
Antitrust ,
Generics ,
Ay For Delay Deals ,
Patent Litigation ,
Patent Lawsuits ,
Settlement ,
Fierce Pharma Homepage ,
Pharma ,